News
In a phase 3, open-label safety extension study, researchers evaluated the safety of oral edaravone in patients with amyotrophic lateral sclerosis over 96 weeks.
HealthDay News — Weeks after ordering staff back to the office, the US Food and Drug Administration (FDA) is now letting some employees work from home again. The move follows major staff cuts and ...
Parkinson disease (PD) is associated with a greater prevalence of arrhythmias among hospitalized adults and may increase the risk for mortality, according to study results presented at the American ...
Just over half of Americans (51%) are considered cost-secure (facing no recent difficulty accessing or affording care or paying for prescription medicine), the lowest level since 2021.
HealthDay News — The Trump administration has let go of the last remaining US health officials who oversaw HIV care for more than 1.1 million mothers and children in low-income countries. The move ...
Artificial intelligence (AI) can accurately suggest appropriate adjuvant treatment for patients with early breast cancer, according to research published in JCO Clinical Cancer Informatics.
Based on these findings, the USPSTF concludes that primary care behavioral counseling interventions to support breastfeeding have a moderate net benefit, with moderate certainty. Interventions or ...
Semaglutide use associated with increased risk for NAION at the 2-, 3-, and 4-year time point from the index date.
Erzofri is an atypical antipsychotic that is administered once a month as an intramuscular injection by a health care professional.
In a webinar hosted by ANAC, speakers discuss how providers can make transgender patients feel more trusting and accepted in ...
C, shares how she saved Dr Jacquelyn Lacera’s life from a near-fatal cardiovascular event while aboard a flight from Hawaii.
The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics Application (sBLA) for fremanezumab-vfrm to include the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results